Source:http://linkedlifedata.com/resource/pubmed/id/14973950
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-2-19
|
pubmed:abstractText |
Tardive dyskinesia is a disfiguring movement disorder of the orofacial region often caused by antipsychotic drugs. A wide range of strategies has been used to help manage tardive dyskinesia and, for people who are unable to have their antipsychotic medication stopped or substantially changed, the calcium-channel blocking group of drugs (diltiazem, nifedipine, nimodipine, verapamil) has been suggested as a useful adjunctive treatment.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1469-493X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CD000206
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14973950-Antipsychotic Agents,
pubmed-meshheading:14973950-Calcium Channel Blockers,
pubmed-meshheading:14973950-Dyskinesia, Drug-Induced,
pubmed-meshheading:14973950-Humans,
pubmed-meshheading:14973950-Randomized Controlled Trials as Topic,
pubmed-meshheading:14973950-Schizophrenia
|
pubmed:year |
2004
|
pubmed:articleTitle |
Calcium channel blockers for neuroleptic-induced tardive dyskinesia.
|
pubmed:affiliation |
Department of Social Work, Bar llan University, 82 Jerusalem Street, Kfar-Saba, Israel.
|
pubmed:publicationType |
Journal Article,
Review
|